<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR102">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Das</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Norris</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Padmanabha</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Moquin</surname>
    <given-names>RV</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>2-Aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward thediscovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl] amino)]-1, 3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor</article-title>
  <source>J Medicianl Chem</source>
  <year>2006</year>
  <volume>49</volume>
  <fpage>6819</fpage>
  <lpage>32</lpage>
  <pub-id pub-id-type="doi">10.1021/jm060727j</pub-id>
 </element-citation>
</ref>
